Global Optical Genome Mapping Market Report and Forecast 2024-2032

Global Optical Genome Mapping Market Outlook

The global optical genome mapping market size is anticipated to grow at a CAGR of 19.7% during the forecast period of 2024-2032, driven by the increasing accessibility and affordability of technology in the field across the globe.

Optical Genome Mapping: Introduction

Optical genome mapping is an innovative technology which enables the comprehensive analysis and mapping of the entire genome of an organism. Optical genome mapping (OGM) images extra-long linear, and single DNA molecules (median size > 250 kb) that are labeled at certain locations. This tedious technique has been updated by Bionano Genomics and is now popular as “optical mapping for structural variation analysis by whole-genome mapping.

Optical genome mapping allows researchers and scientists to study genetic differences, structural rearrangements, and other genomic alterations with high accuracy and resolution. Optical genome mapping provides valuable insights into genomic disorders, cancer research, personalized medicine, and other fields of genomics.

Global Optical Genome Mapping Market Analysis

The continuous advancements in technology is leading to improved efficiency, accuracy, and scalability of the optical genome mapping platforms, resulting in optical genome mapping market growth. The development in optical genome mapping platforms has enabled faster and more cost-effective genome mapping, making it more accessible to researchers and clinicians. The increasing use of optical genome mapping platforms to detect and analyze genetic abnormalities related to several diseases and disorders is taking place. It provides a detailed view of the genome, allowing for the identification of structural differences.

Optical Genome Mapping Market Segmentations

Market Breakup by Product

• Consumables 

• Instruments

Market by Application

• Genome Assembly

• Structural Variation Detection

• Microbial Strain Typing

• Haplotype Phasing

• Others

Market by End User

• Research and Academic Institutions

• Biotechnology and Pharmaceutical Companies

• Clinical Laboratories

• Others

Market Breakup by Region

• North America  

• Europe 

• Asia Pacific 

• Latin America 

• Middle East and Africa

Optical Genome Mapping Market Overview

The rapid advancements in genomics research, increasing demand for personalized medicine, and the need for detailed genomic analysis are some of the key factors which are aiding the optical genome mapping market expansion. Optical genome mapping technologies have been revolutionizing the way studies were done in order to understand genome, providing high-resolution mapping of genomic versions and structural dislocations. These technologies have discovered uses in several areas, including clinical diagnostics, pharmaceutical research, and agriculture.

The market for optical genome mapping is expected to grow due to the increased accessibility and affordability of technology in the field. Growing advancements in equipment design, automation, and data analysis algorithms are making optical genome mapping platforms more user-friendly and efficient. Due to this factor, the integration of optical genome mapping platforms is done in research and clinical workflows in order to achieve faster and more accurate analysis of genomic data.

Optical Genome Mapping Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Bionano Genomics, Inc. 

• Nucleome Informatics Pvt Ltd 

• PerkinElmer, Inc. 

• Nabsys Inc. 

• France Génomique 

• Praxis Genomics LLC 

• OpGen, Inc. 

• Thermo Fisher Scientific, Inc. 

• Illumina, Inc. 

• HemoCue Holding AB

Key Highlights of the Report